300 related articles for article (PubMed ID: 31266632)
21. Sleeve gastrectomy ameliorated high-fat diet (HFD)-induced non-alcoholic fatty liver disease and upregulated the nicotinamide adenine dinucleotide +/ Sirtuin-1 pathway in mice.
Hua R; Wang GZ; Shen QW; Yang YP; Wang M; Wu M; Shao YK; He M; Zang Y; Yao QY; Zhang ZY
Asian J Surg; 2021 Jan; 44(1):213-220. PubMed ID: 32712045
[TBL] [Abstract][Full Text] [Related]
22. TSH-SPP1/TRβ-TSH positive feedback loop mediates fat deposition of hepatocyte: Crosstalk between thyroid and liver.
Huang B; Wen W; Ye S
Front Immunol; 2022; 13():1009912. PubMed ID: 36300106
[TBL] [Abstract][Full Text] [Related]
23. Hyperoside attenuates non-alcoholic fatty liver disease through targeting Nr4A1 in macrophages.
Sun B; Zhang R; Liang Z; Fan A; Kang D
Int Immunopharmacol; 2021 May; 94():107438. PubMed ID: 33611063
[TBL] [Abstract][Full Text] [Related]
24. Hepatocyte high-mobility group box 1 protects against steatosis and cellular stress during high fat diet feeding.
Lin M; Long J; Li W; Yang C; Loughran P; O'Doherty R; Billiar TR; Deng M; Scott MJ
Mol Med; 2020 Nov; 26(1):115. PubMed ID: 33238880
[TBL] [Abstract][Full Text] [Related]
25. Impaired Hepatic Vitamin A Metabolism in NAFLD Mice Leading to Vitamin A Accumulation in Hepatocytes.
Saeed A; Bartuzi P; Heegsma J; Dekker D; Kloosterhuis N; de Bruin A; Jonker JW; van de Sluis B; Faber KN
Cell Mol Gastroenterol Hepatol; 2021; 11(1):309-325.e3. PubMed ID: 32698042
[TBL] [Abstract][Full Text] [Related]
26. MD2 deficiency prevents high-fat diet-induced AMPK suppression and lipid accumulation through regulating TBK1 in non-alcoholic fatty liver disease.
Luo W; Ye L; Hu XT; Wang MH; Wang MX; Jin LM; Xiao ZX; Qian JC; Wang Y; Zuo W; Huang LJ; Liang G
Clin Transl Med; 2022 Mar; 12(3):e777. PubMed ID: 35343085
[TBL] [Abstract][Full Text] [Related]
27. Juglanin protects against high fat diet-induced renal injury by suppressing inflammation and dyslipidemia via regulating NF-κB/HDAC3 signaling.
Li Q; Ge C; Tan J; Sun Y; Kuang Q; Dai X; Zhong S; Yi C; Hu LF; Lou DS; Xu M
Int Immunopharmacol; 2021 Jun; 95():107340. PubMed ID: 33667999
[TBL] [Abstract][Full Text] [Related]
28. STUB1 increases adiponectin expression by inducing ubiquitination and degradation of NR2F2, thereby reducing hepatic stellate cell activation and alleviating non-alcoholic fatty liver disease.
Mao Z; Zhao J; Cui F; Li Z; Cao J; Zhou J; Hou M; Qian Z
Tissue Cell; 2024 Jun; 88():102345. PubMed ID: 38471267
[TBL] [Abstract][Full Text] [Related]
29. Knockout of STE20-type kinase TAOK3 does not attenuate diet-induced NAFLD development in mice.
Xia Y; Andersson E; Caputo M; Cansby E; Sedda F; Font-Gironès F; Ruud J; Kurhe Y; Hallberg B; Marschall HU; Asterholm IW; Romeo S; Blüher M; Mahlapuu M
Mol Med; 2023 Oct; 29(1):138. PubMed ID: 37864157
[TBL] [Abstract][Full Text] [Related]
30. A high-fat diet supplemented with medium-chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice.
Mourad S; Abdualkader AM; Li X; Jani S; Ceddia RB; Al Batran R
Exp Physiol; 2024 Mar; 109(3):350-364. PubMed ID: 38192209
[TBL] [Abstract][Full Text] [Related]
31. YIPF6 controls sorting of FGF21 into COPII vesicles and promotes obesity.
Wang L; Mazagova M; Pan C; Yang S; Brandl K; Liu J; Reilly SM; Wang Y; Miao Z; Loomba R; Lu N; Guo Q; Liu J; Yu RT; Downes M; Evans RM; Brenner DA; Saltiel AR; Beutler B; Schnabl B
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15184-15193. PubMed ID: 31289229
[TBL] [Abstract][Full Text] [Related]
32. Role of Chitinase 3-Like 1 Protein in the Pathogenesis of Hepatic Insulin Resistance in Nonalcoholic Fatty Liver Disease.
Zhang S; Sousa A; Lin M; Iwano A; Jain R; Ma B; Lee CM; Park JW; Kamle S; Carlson R; Lee GG; Elias JA; Wands JR
Cells; 2021 Jan; 10(2):. PubMed ID: 33498326
[TBL] [Abstract][Full Text] [Related]
33. DEAD-Box Helicase 17 exacerbates non-alcoholic steatohepatitis via transcriptional repression of cyp2c29, inducing hepatic lipid metabolism disorder and eliciting the activation of M1 macrophages.
Ning D; Jin J; Fang Y; Du P; Yuan C; Chen J; Huang Q; Cheng K; Mo J; Xu L; Guo H; Yang MJ; Chen X; Liang H; Zhang B; Zhang W
Clin Transl Med; 2024 Feb; 14(2):e1529. PubMed ID: 38303609
[TBL] [Abstract][Full Text] [Related]
34. MERTK
Junior ; Lai YS; Nguyen HT; Salmanida FP; Chang KT
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638941
[TBL] [Abstract][Full Text] [Related]
35. Perilipin 5 regulates hepatic stellate cell activation and high-fat diet-induced non-alcoholic fatty liver disease.
Yin X; Dong L; Wang X; Qin Z; Ma Y; Ke X; Li Y; Wang Q; Mi Y; Lyu Q; Xu X; Zheng P; Tang Y
Animal Model Exp Med; 2024 Apr; 7(2):166-178. PubMed ID: 37202925
[TBL] [Abstract][Full Text] [Related]
36. Decreased autophagosome biogenesis, reduced NRF2, and enhanced ferroptotic cell death are underlying molecular mechanisms of non-alcoholic fatty liver disease.
Liu P; Anandhan A; Chen J; Shakya A; Dodson M; Ooi A; Chapman E; White E; Garcia JG; Zhang DD
Redox Biol; 2023 Feb; 59():102570. PubMed ID: 36495698
[TBL] [Abstract][Full Text] [Related]
37. Nutrient-sensing growth hormone secretagogue receptor in macrophage programming and meta-inflammation.
Kim DM; Lee JH; Pan Q; Han HW; Shen Z; Eshghjoo S; Wu CS; Yang W; Noh JY; Threadgill DW; Guo S; Wright G; Alaniz R; Sun Y
Mol Metab; 2024 Jan; 79():101852. PubMed ID: 38092245
[TBL] [Abstract][Full Text] [Related]
38. Foxa2 attenuates steatosis and inhibits the NF-κB/IKK signaling pathway in nonalcoholic fatty liver disease.
Yang L; Ma Q; Chen J; Kong X; Yu X; Wang W
PeerJ; 2023; 11():e16466. PubMed ID: 38084145
[TBL] [Abstract][Full Text] [Related]
39. Hepatic interleukin-1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver disease.
Gehrke N; Hofmann LJ; Straub BK; Rühle F; Waisman A; Galle PR; Schattenberg JM
Clin Transl Med; 2022 Sep; 12(9):e1048. PubMed ID: 36101976
[TBL] [Abstract][Full Text] [Related]
40. Galectin-12 modulates Kupffer cell polarization to alter the progression of nonalcoholic fatty liver disease.
Lee JL; Wang YC; Hsu YA; Chen CS; Weng RC; Lu YP; Chuang CY; Wan L
Glycobiology; 2023 Oct; 33(8):673-682. PubMed ID: 37504513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
